Owens & Minor, Inc. (NYSE:OMI) Given Average Rating of “Hold” by Brokerages

Owens & Minor, Inc. (NYSE:OMI) has received a consensus rating of “Hold” from the eight analysts that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $20.00.

Several research firms have issued reports on OMI. Citigroup raised shares of Owens & Minor from a “neutral” rating to a “buy” rating and cut their price target for the stock from $24.00 to $19.00 in a report on Friday, July 19th. JPMorgan Chase & Co. decreased their price target on Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a research note on Wednesday, August 21st. StockNews.com downgraded shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Monday, August 26th. Barclays cut their price target on shares of Owens & Minor from $23.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Monday, August 5th. Finally, Bank of America dropped their price objective on shares of Owens & Minor from $18.00 to $16.00 and set an “underperform” rating on the stock in a report on Tuesday, June 25th.

Owens & Minor Stock Performance

Shares of OMI stock opened at $14.57 on Thursday. The firm has a market cap of $1.11 billion, a price-to-earnings ratio of -28.57, a PEG ratio of 0.50 and a beta of 0.39. Owens & Minor has a 52-week low of $12.36 and a 52-week high of $28.35. The company has a quick ratio of 0.51, a current ratio of 1.09 and a debt-to-equity ratio of 2.17. The company’s 50 day moving average is $15.15 and its 200 day moving average is $19.29.

Owens & Minor (NYSE:OMI) last issued its quarterly earnings data on Friday, August 2nd. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.03. The firm had revenue of $2.67 billion during the quarter, compared to analysts’ expectations of $2.65 billion. Owens & Minor had a positive return on equity of 14.66% and a negative net margin of 0.40%. The firm’s quarterly revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.18 EPS. On average, sell-side analysts anticipate that Owens & Minor will post 1.57 EPS for the current fiscal year.

Hedge Funds Weigh In On Owens & Minor

Several institutional investors and hedge funds have recently modified their holdings of the business. Riverview Trust Co purchased a new stake in shares of Owens & Minor during the first quarter worth about $25,000. Quarry LP raised its stake in Owens & Minor by 290.1% in the 2nd quarter. Quarry LP now owns 2,099 shares of the company’s stock valued at $28,000 after purchasing an additional 1,561 shares during the last quarter. Quest Partners LLC purchased a new position in Owens & Minor in the 4th quarter valued at $41,000. Hexagon Capital Partners LLC grew its holdings in shares of Owens & Minor by 1,240.2% during the first quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company’s stock worth $43,000 after buying an additional 1,451 shares in the last quarter. Finally, Innealta Capital LLC acquired a new stake in shares of Owens & Minor in the second quarter valued at about $43,000. Hedge funds and other institutional investors own 98.04% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.